BiotechTube
Poly Pharmaceuticals

Poly Pharmaceuticals

Lincoln, United States· Est.
polypharm.net
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Poly Pharmaceuticals is a US-based, private CDMO and product development company with a history dating back to 1980. It operates in the generic and OTC drug sectors, developing and manufacturing cost-effective medications for common health conditions. The company leverages a service-based business model, offering formulation development and manufacturing to partners while also marketing its own portfolio of products. Its strategy centers on portfolio growth through business development and operational execution in a competitive generics market.

Cough/ColdAllergySinusitisPain ReliefUrological Health

Technology Platform

Integrated CDMO services for pharmaceutical formulation development, scale-up, and commercial manufacturing, with expertise in generic and OTC solid and liquid dosage forms.

Opportunities

Growth in the outsourced pharmaceutical manufacturing (CDMO) market and consistent demand for low-cost generic and OTC medications provide a stable market foundation.
Opportunities exist to expand through strategic acquisitions, licensing of ANDAs, and securing contracts for manufacturing complex generics.

Risk Factors

Faces intense price competition and margin pressure in the generic drug and CDMO sectors.
Regulatory compliance risks, including FDA inspections and ANDA approval delays, are significant.
Supply chain disruptions for raw materials could impact production.

Competitive Landscape

Operates in highly competitive markets against large, diversified CDMOs (e.g., Catalent, Lonza) and major generic drug manufacturers (e.g., Teva, Viatris). Competitors often have greater scale, broader global footprints, and more substantial financial resources.

More companies in Small Molecule Drugs →More companies in United States →